Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium for colorectal adenoma recurrence prevention
NCT04952129Phase 1Completed
- Sponsor
- The University of Auckland
- Start
- May 2022
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of selenomethionine and Methylselenocysteine in Colorectal Adenoma (CRA), sponsored by The University of Auckland. Primary endpoint: Plasma selenoprotein P concentration at 12 weeks. Started May 2022; status: completed.
02
Drugs
selenomethionineMethylselenocysteine
03
Conditions
Colorectal Adenoma (CRA)
Beyond the preview
Go deeper on NCT04952129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04952129.